Skip to main content
. 2022 Jul 8;2022:5228874. doi: 10.1155/2022/5228874

Figure 2.

Figure 2

CircACAP2 serves as a ceRNA of miR-193a-5p in cervical cancer cells. (a) The predicted interaction site between circACAP2 and miR-193a-5p. (b), (c) SiHa and HeLa cells treated with miR-193a-5p mimic. The treatment efficacy of miR-193a-5p mimic was determined by qRT-PCR assay. (c) The luciferase activity of circACAP2 analyzed by dual luciferase reporter assay. (d) SiHa and HeLa cells treated with circACAP2 siRNA. The expression of miR-193a-5p was examined by qRT-PCR assay. (e) The interaction of circACAP2 and miR-193a-5p measured by RNA pull-down assay. ∗∗P < 0.01.